Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 110
Phase 24

Trial Status

Completed12
Recruiting2
Terminated1
Other2

Role Distribution

Principal Investigator17
PI Rate100%

Activity Timeline

Clinical Trials (17)

NCT07599176Phase 1/2Recruiting
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Beta-thalassemiaSickle Cell Disease
PrincipalinvestigatorStart date: 2026-07-08
NCT06313398Early Phase 1Recruiting
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
HemoglobinopathySickle Cell DiseaseThalassemia
PrincipalinvestigatorStart date: 2024-05-17
NCT05357482Phase 1/2Active Not Recruiting
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
Beta ThalassemiaSickle Cell Anemia
PrincipalinvestigatorStart date: 2022-05-12
NCT04476277Early Phase 1Completed
Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease
Sickle Cell AnemiaSickle Cell Disease
PrincipalinvestigatorStart date: 2021-04-19
NCT04349189Completed
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Hypercoagulable StateSickle Cell DiseaseSickle Cell Trait+2 more
PrincipalinvestigatorStart date: 2020-09-01
NCT03226691Phase 1Completed
Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients
Sickle Cell Disease
PrincipalinvestigatorStart date: 2017-07-25
NCT00061568Phase 1/2Active Not Recruiting
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Congenital Hemolytic AnemiaSickle Cell Disease
PrincipalinvestigatorStart date: 2004-07-16
NCT00033774Terminated
Stem Cell Collection for Adult Volunteers
Sickle Cell
PrincipalinvestigatorStart date: 2002-04-29
NCT00012545Completed
Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease
Sickle Cell DiseaseSickle Cell Trait
PrincipalinvestigatorStart date: 2001-11-01
NCT00023296Phase 1Completed
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension
Pulmonary HypertensionSickle Cell Anemia
Principalinvestigator

Showing 10 of 17 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Venous ThromboembolismChronic Kidney Diseases
Similarity Score5%

Seetha Shankaran, MD

Wayne State University

Related
49 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

MallinckrodtNational Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Dale L. Phelps, MD

University of Rochester

Related
10 trials

Shared therapeutic areas:

Hypertension, Pulmonary
Similarity Score3%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Chronic Kidney Diseases
Similarity Score3%

Michele C. Walsh, MD MS

Case Western Reserve University, Rainbow Babies and Children's Hospital

Related
11 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Neil N. Finer, MD

University of California, San Diego

Related
11 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Edward F. Donovan, MD

Children's Hospital Medical Center, Cincinnati

Related
21 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

Mallinckrodt
Similarity Score3%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Venous Thromboembolism
Similarity Score3%

Barbara J. Stoll, MD

Emory University

Related
33 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

MallinckrodtNational Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (17)

Showing 17 of 17 trials

NCT07599176Phase 1/2PrincipalInvestigator

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Beta-thalassemiaSickle Cell Disease
Recruiting
NCT06313398Early Phase 1PrincipalInvestigator

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

HemoglobinopathySickle Cell DiseaseThalassemia
Recruiting
NCT05357482Phase 1/2PrincipalInvestigator

Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia

Beta ThalassemiaSickle Cell Anemia
Active Not Recruiting
NCT04476277Early Phase 1PrincipalInvestigator

Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease

Sickle Cell AnemiaSickle Cell Disease
Completed
NCT04349189PrincipalInvestigator

Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait

Hypercoagulable StateSickle Cell DiseaseSickle Cell Trait+2 more
Completed
NCT03226691Phase 1PrincipalInvestigator

Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients

Sickle Cell Disease
Completed
NCT00061568Phase 1/2PrincipalInvestigator

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Congenital Hemolytic AnemiaSickle Cell Disease
Active Not Recruiting
NCT00033774PrincipalInvestigator

Stem Cell Collection for Adult Volunteers

Sickle Cell
Terminated
NCT00012545PrincipalInvestigator

Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease

Sickle Cell DiseaseSickle Cell Trait
Completed
NCT00023296Phase 1PrincipalInvestigator

Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension

Pulmonary HypertensionSickle Cell Anemia
Completed
NCT00056433Phase 1PrincipalInvestigator

Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia

Sickle Cell Anemia
Completed
NCT00072826Phase 1PrincipalInvestigator

Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease

Sickle Cell Disease
Completed
NCT00095472Phase 1PrincipalInvestigator

Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

Sickle Cell Anemia
Completed
NCT00270478Phase 1PrincipalInvestigator

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

Chronic Kidney DiseasePulmonary HypertensionSickle Cell Disease
Completed
NCT00352430Phase 1PrincipalInvestigator

Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension

Pulmonary Hypertension
Completed
NCT00508989Phase 2PrincipalInvestigator

Niacin to Improve Blood Flow in People With Sickle Cell Disease

Sickle Cell Disease
Completed
NCT01547793PrincipalInvestigator

Carbon Monoxide Levels and Sickle Cell Disease Severity

Anemia, Sickle CellSickle Cell AnemiaSickle Cell Disease
Completed

All 17 trials loaded